The Agency has qualified Apple's atrial fibrillation history feature as a medical device development tool, allowing it to be used in clinical trials.
Also, Clanwilliam has formally established its ANZ division.
The open-source gene editor is freely available to license for commercial use and ethical research.
The Agency alleges the company's CT and ultrasonography systems are noncompliant with good manufacturing requirements.
The company will use the funds to accelerate its AI capabilities and for strategic and commercial growth.
Dr. Julia Frydman will be the oncology-focused company's first medical director for palliative care. She will oversee its new Enhanced Supportive Care program.
The new platform for will offer video visits for rare disease diagnosis and longitudinal care.
Business model is unsustainable due to a challenging reimbursement environment and escalating operating costs, company says.
The health tech giant reported lower-than-expected sales and profits in the first quarter, resulting in its shares plummeting.
GenAI company for health plans Alaffia Health and oncology-focused clinical-trial platform Klineo also secured funding.
